CClinicalTrials.gg
RecruitingNCT05629416Updated Feb 16, 2023

The Communicate Study Partnership

A Phase 2 interventional study of Interventions to transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples in Aboriginal Health, Cultural Safety and Access to Interpreters, sponsored by Menzies School of Health Research. Recruiting at 4 sites in Australia. Per ClinicalTrials.gov, last updated 2023-02-16.

Sponsored by Menzies School of Health Research · Phase 2, Interventional, and Health services research

Phase
Phase 2
Study type
Interventional
Enrollment
340
Allocation
Not applicable
Sex
All
01

Study summary

The vision of the Communicate Study Partnership is to ensure more Aboriginal patients receive culturally safe healthcare in their first language.

The Communicate Study Partnership will implement and evaluate creative ways to embed cultural safety training and increase use of Aboriginal Interpreters and Aboriginal Health Practitioners at Northern Territory Top End hospitals.

Quantitative outcomes (interpreter uptake, outcomes including leave against medical advice, costs) will be measured using time-series analysis. Qualitative outcomes derived from interviews with patient, healthcare provider and interpreter participants, will be informed by decolonising theory and participatory approaches.

Successful project implementation will improve experience of care and health outcomes for Aboriginal people, build Aboriginal workforce, and improve healthcare provider satisfaction.

Read the detailed description

The goal of "The Communicate Study: partnership across the Top End to improve Aboriginal patients' experience and outcomes of healthcare" is to achieve sustainable organisational change to provide excellence in cultural and clinical safety for Aboriginal people utilising NT Health facilities.

Aim 1: Transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples

  • Develop, implement and evaluate anti-racism training using 'Ask the specialist-Plus'. This comprises moderated discussion and reflection on 'Ask the Specialist' podcast episodes held during in-service and clinical teaching timeslots for healthcare providers

Aim 2: Strengthen the tools and strategies required underpinning culturally safe practice

  1. Improve demand for Aboriginal interpreters and Aboriginal health practitioners through improved cultural understanding and recognition of patient needs
  2. Improve supply of interpreters and Aboriginal health practitioners willing to work in the hospital environment by creating a culturally safe workplace and supporting career pathways
  3. Effectiveness strategies tailored to participating sites such as

    • positioning interpreters at points of need and embedding them in medical and surgical teams
    • Optimising workflow to facilitate efficiency and availability across hospital departments

Aim 3: Evaluate outcomes using comprehensive qualitative and quantitative measures

  1. Qualitative enquiry to assess cultural safety from patient perspectives, and understand experiences of Aboriginal and Non-Aboriginal healthcare providers and interpreters
  2. Quantitative outcomes including

    • performance across key indicators: changes in documentation of language; Interpreter bookings made; Interpreter bookings completed; % Aboriginal patients in need getting access to an interpreter
    • Impact of intervention: proportion of admissions with and without interpreters ending in self-discharge; unplanned re-admissions and changes in hospital length of stay
    • economic analysis of the costs and cost benefits of interpreter use to decrease self-discharge and re-admission rates.
02

Conditions studied

  • Aboriginal Health
  • Cultural Safety
  • Access to Interpreters
  • Healthcare Provider Training
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Different patient and provider participants (e.g. Aboriginal patients, Aboriginal interpreters, healthcare providers of any ethnicity) will be invited to participate in interviews, observations and surveys to assess effectiveness of study activities

Exclusion criteria

Exclusion Criteria:

None

04

Study design

Phase
Phase 2
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
340 participants (estimated)

Study arms

  • Experimental
    Cultural safety training and behaviour change intervention

    - Interventions to transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples

    Behavioral: Interventions to transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples

Interventions

  • BehavioralInterventions to transform the culture of healthcare systems to achieve excellence in providing culturally safe care for First Nations peoples

    1. Implement 'Ask the Specialist Plus', a structured program to promote anti-racism within Northern Territory (NT) hospitals by giving healthcare providers training in cultural safety. 2. Implement strategies to foster 'Clinical champions of cultural safety' through a social media chat platform and face to face meetings to discuss anti-racism practice, cultural safety and practical ways to deliver culturally safe care including interpreter use. 3. Support simplified and improved strategies for booking an interpreter to increase uptake. 4. Implement retention strategies to ensure interpreters receive workplace support. 5. Provide training in health terminology for interpreters. 6. Integrate interpreter supply and demand through efficiency and effectiveness strategies tailored to participating sites. 7. Implement continuous quality improvement cycles with senior managers, using findings from qualitative and quantitative data collection and evaluation.

05

What researchers measure

Primary outcomes

  1. Self discharge among Aboriginal inpatients at Royal Darwin Hospital, Palmerston Hospital, Katherine Hospital and Gove District Hospital

    Self discharge (also referred to as 'Discharge against medical advice,', 'take own leave' or 'incomplete care') will be assessed among all admitted Aboriginal patients every quarter as a measure of the effeciveness of hospital-level study activities * Measured as proportion of all admissions of Aboriginal people that end in self-discharge * Data source: hospital Admitted Patient Care dataset (routinely collected by health services) The study has a two-year baseline phase July 1 2020 - June 30 2022, and four-year intervention (activity) period July 1 2022 - June 30 2026. There are no individually enrolled participants followed up at given time points; instead, activities are implemented continually at the level of the health systems, and outcomes are assessed using continuous hospital data and qualitative data, summarised quarterly.

    Time frame: Up to 4 years. (Health system level data are collected and summarised quarterly during July 1 2022 - June 30 2026, and compared with the baseline phase July 1 2020 - June 30 2022)

  2. Patient experience (qualitative evaluation)

    Patient experience pre- and post-implementation of the interventions will be assessed through in-depth 30-60 minute one-on-one, face-to-face interviews of inpatients and patients who have recently (within 14 days) been discharged, by a member of the research team. The research team member will speak the patient's first language, or will work with an Aboriginal interpreter to conduct the interview. Some individuals with repeated contact with healthservices (such as renal dialysis patients) will be invited to participate in serial interviews over time

    Time frame: Up to 4 years. Interview data will be collected at regular intervals throughout the study (2022-2026) to track any change in patient experience during the course of the intervention period

Secondary outcomes

  1. Documentation of language in hospital medical records

    Adequacy of documentation (proportion of Aboriginal patients for whom language is documented) will be used to inform quarterly quality improvement data review meetings. Data source: hospital electronic system (currently CARESYS, transitioning during the study period to ACACIA)

    Time frame: Up to 4 years. (Documentation of language will be tracked throughout the 4-year intervention period.)

  2. Access to an interpreter during admission

    Interpreter access (proportion of Aboriginal patients with a language other than English as their first language) will be used to inform quarterly quality improvement data review meetings.

    Time frame: Up to 4 years. (Documentation of interpreter access will be tracked throughout the 4-year intervention period.)

  3. Healthcare provider experience

    Healthcare provider experience of working with Aboriginal interpreters (qualitative evaluation) assessed by 30 minute semi-structured one-on-one, face-to-face interviews of healthcare providers with a member of the research team.

    Time frame: Up to 4 years. Interview data will be collected at regular intervals throughout the study (2022-2026) to track any change in healthcare provider experience during the course of the intervention period

  4. Cost

    Healthcare costs will be calculated based on variables including the top 6 ICD codes per admission and hospital length of stay. Economic evaluation will be conducted from the payer perspective and include the linked Admitted Patient Care and Aboriginal Interpreter Service datasets and NTHTE Unit expenditure reports, as well as ICD codes and Australian Refined DRGs.

    Time frame: Up to 4 years. Continuous data (daily data, summarised monthly) will be assessed during - the two-year baseline phase July 1 2020 - June 30 2022 - the four-year intervention (activity) period July 1 2022 - June 30 2026

  5. Unplanned readmission within 28 days

    Continuous data collated monthly

    Time frame: Up to 4 years. Continuous data (daily data, summarised monthly) will be assessed during - the two-year baseline phase July 1 2020 - June 30 2022 - the four-year intervention (activity) period July 1 2022 - June 30 2026

06

Study locations

1 of 4 sites recruiting
  • Royal Darwin Hospital
    Darwin, Northern Territory 0810, Australia
    Recruiting
  • Palmerston Hospital
    Darwin, Northern Territory 0830, Australia
    Not yet recruiting
  • Katherine Hospital
    Katherine, Northern Territory 0850, Australia
    Not yet recruiting
  • Gove District Hospital
    Nhulunbuy, Northern Territory 0880, Australia
    Not yet recruiting
07

References and documents

Publications

  • Kerrigan V, McGrath SY, Herdman RM, Puruntatameri P, Lee B, Cass A, Ralph AP, Hefler M. Evaluation of 'Ask the Specialist': a cultural education podcast to inspire improved healthcare for Aboriginal peoples in Northern Australia. Health Sociol Rev. 2022 Jul;31(2):139-157. doi: 10.1080/14461242.2022.2055484. Epub 2022 Apr 3. PubMed 35373706 ↗
  • O'Connor E, Kerrigan V, Aitken R, Castillon C, Mithen V, Madrill G, Roman C, Ralph AP. Does improved interpreter uptake reduce self-discharge rates in hospitalised patients? A successful hospital intervention explained. PLoS One. 2021 Oct 12;16(10):e0257825. doi: 10.1371/journal.pone.0257825. eCollection 2021. PubMed 34637434 ↗
  • Kerrigan V, McGrath SY, Majoni SW, Walker M, Ahmat M, Lee B, Cass A, Hefler M, Ralph AP. "The talking bit of medicine, that's the most important bit": doctors and Aboriginal interpreters collaborate to transform culturally competent hospital care. Int J Equity Health. 2021 Jul 23;20(1):170. doi: 10.1186/s12939-021-01507-1. PubMed 34301261 ↗
  • Kerrigan V, McGrath SY, Majoni SW, Walker M, Ahmat M, Lee B, Cass A, Hefler M, Ralph AP. From "stuck" to satisfied: Aboriginal people's experience of culturally safe care with interpreters in a Northern Territory hospital. BMC Health Serv Res. 2021 Jun 4;21(1):548. doi: 10.1186/s12913-021-06564-4. PubMed 34088326 ↗
  • Mithen V, Kerrigan V, Dhurrkay G, Morgan T, Keilor N, Castillon C, Hefler M, Ralph AP. Aboriginal patient and interpreter perspectives on the delivery of culturally safe hospital-based care. Health Promot J Austr. 2021 Feb;32 Suppl 1:155-165. doi: 10.1002/hpja.415. Epub 2020 Dec 4. PubMed 32888378 ↗
  • Communicate Study group*. Improving communication with Aboriginal hospital inpatients: a quasi-experimental interventional study. Med J Aust. 2020 Aug;213(4):180-181. doi: 10.5694/mja2.50700. Epub 2020 Jul 25. No abstract available. PubMed 32710454 ↗
  • Kerrigan V, Lewis N, Cass A, Hefler M, Ralph AP. "How can I do more?" Cultural awareness training for hospital-based healthcare providers working with high Aboriginal caseload. BMC Med Educ. 2020 May 29;20(1):173. doi: 10.1186/s12909-020-02086-5. PubMed 32471490 ↗
  • Ralph AP, Lowell A, Murphy J, Dias T, Butler D, Spain B, Hughes JT, Campbell L, Bauert B, Salter C, Tune K, Cass A. Low uptake of Aboriginal interpreters in healthcare: exploration of current use in Australia's Northern Territory. BMC Health Serv Res. 2017 Nov 15;17(1):733. doi: 10.1186/s12913-017-2689-y. PubMed 29141623 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT05629416
Lead sponsor
Menzies School of Health Research
Collaborators
Northern Territory of Australia as represented by the Department of Health, Djalkiri Foundation Aboriginal Corporation, Charles Darwin University, National Accreditation Authority for Translators and Interpreters, Northern Territory Government as represented by the Department of The Chief Minister and Cabinet
Responsible party
Sponsor
First posted
Nov 29, 2022
Start date
May 23, 2022
Primary completion
May 11, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 16, 2023

Study contacts

Anna Ralph, PhD
Contact
anna.ralph@menzies.edu.au
+618 89468647
Victoria Kerrigan, PhD
Contact
vicki.kerrigan@menzies.edu.au
+61889468600
Anna Ralph, PhD
principal investigator · Menzies School of Health Research

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion